CN106164290A - 使用mirna比率确定肺癌 - Google Patents

使用mirna比率确定肺癌 Download PDF

Info

Publication number
CN106164290A
CN106164290A CN201480076735.0A CN201480076735A CN106164290A CN 106164290 A CN106164290 A CN 106164290A CN 201480076735 A CN201480076735 A CN 201480076735A CN 106164290 A CN106164290 A CN 106164290A
Authority
CN
China
Prior art keywords
mirna
ratio
expression
mir
pair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480076735.0A
Other languages
English (en)
Chinese (zh)
Inventor
G.索兹
M.贝里
U.帕斯托里诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baio Milner Holdings Ltd
Original Assignee
Baio Milner Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baio Milner Holdings Ltd filed Critical Baio Milner Holdings Ltd
Publication of CN106164290A publication Critical patent/CN106164290A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
CN201480076735.0A 2014-01-05 2014-12-31 使用mirna比率确定肺癌 Pending CN106164290A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461923758P 2014-01-05 2014-01-05
US61/923758 2014-01-05
US201461926323P 2014-01-12 2014-01-12
US61/926323 2014-01-12
PCT/EP2014/079499 WO2015101653A1 (en) 2014-01-05 2014-12-31 Lung cancer determinations using mirna ratios

Publications (1)

Publication Number Publication Date
CN106164290A true CN106164290A (zh) 2016-11-23

Family

ID=52347306

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480076735.0A Pending CN106164290A (zh) 2014-01-05 2014-12-31 使用mirna比率确定肺癌

Country Status (10)

Country Link
US (4) US20150191794A1 (https=)
EP (2) EP3090059B1 (https=)
JP (2) JP6706208B2 (https=)
CN (1) CN106164290A (https=)
AU (1) AU2014375224A1 (https=)
BR (1) BR112016015595A2 (https=)
CA (1) CA2935789A1 (https=)
ES (1) ES2686631T3 (https=)
IL (1) IL246580B (https=)
WO (1) WO2015101653A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114144836A (zh) * 2019-05-08 2022-03-04 丘比株式会社 信息提供装置和miRNA重要度表生成方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11535895B2 (en) * 2017-04-06 2022-12-27 University Of Maryland, Baltimore Methods of detecting lung cancer
IT202100008798A1 (it) * 2021-04-08 2022-10-08 Univ Degli Studi Di Ferrara Uso del microrna hsa-mir-197-3p come marcatore di esposizione all’amianto e di mesotelioma maligno della pleura
CN113278692A (zh) * 2021-05-19 2021-08-20 北京艾克伦医疗科技有限公司 鉴定肺结节状态的方法和试剂盒
US20250059603A1 (en) * 2021-12-15 2025-02-20 Sera Prognastics, Inc. Expanded panels of nucleic acid biomarkers for placental dysfunction
WO2025089028A1 (ja) * 2023-10-24 2025-05-01 アークレイ株式会社 検査方法、検査装置、検査システム、検査プログラム、記録媒体、及び溶血程度学習済モデルの生成方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1367829A (zh) * 1999-06-30 2002-09-04 科里克萨有限公司 用于肺癌治疗和诊断的组合物和方法
CN1370182A (zh) * 1999-04-02 2002-09-18 科里克萨有限公司 用于治疗和诊断肺癌的化合物和方法
CN101284873A (zh) * 1999-06-30 2008-10-15 科里克萨有限公司 用于肺癌治疗和诊断的组合物和方法
CN101918594A (zh) * 2007-11-30 2010-12-15 俄亥俄州立大学研究基金会 肺癌中外周血中的微rna表达特征谱和靶向
WO2012107841A2 (en) * 2011-02-07 2012-08-16 Biomirna Holdings Ltd. Micro-rna biomarkers and methods of using same
CN102725632A (zh) * 2009-08-28 2012-10-10 奥斯瑞根公司 肺病的miRNA生物标志物
CN102858997A (zh) * 2009-11-02 2013-01-02 新加坡科技研究局 用于监测细胞状态和用于永生间充质干细胞的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366860A (en) 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5188934A (en) 1989-11-14 1993-02-23 Applied Biosystems, Inc. 4,7-dichlorofluorescein dyes as molecular probes
DE69131891T2 (de) 1990-02-16 2000-06-15 F. Hoffmann-La Roche Ag, Basel Verbesserungen in der spezifität und zweckmässigkeit der polymerase-kettenreaktion
US5965364A (en) 1990-10-09 1999-10-12 Benner; Steven Albert Method for selecting functional deoxyribonucleotide derivatives
US5432272A (en) 1990-10-09 1995-07-11 Benner; Steven A. Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
US5413924A (en) 1992-02-13 1995-05-09 Kosak; Kenneth M. Preparation of wax beads containing a reagent for release by heating
US5767259A (en) 1994-12-27 1998-06-16 Naxcor Oligonucleotides containing base-free linking groups with photoactivatable side chains
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
CA2168712A1 (en) 1995-02-07 1996-08-08 John William Henderson Sutherland Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction
US6020481A (en) 1996-04-01 2000-02-01 The Perkin-Elmer Corporation Asymmetric benzoxanthene dyes
EP0892808B1 (en) 1996-04-12 2008-05-14 PHRI Properties, Inc. Detection probes, kits and assays
US5800996A (en) 1996-05-03 1998-09-01 The Perkin Elmer Corporation Energy transfer dyes with enchanced fluorescence
US5863727A (en) 1996-05-03 1999-01-26 The Perkin-Elmer Corporation Energy transfer dyes with enhanced fluorescence
US5847162A (en) 1996-06-27 1998-12-08 The Perkin Elmer Corporation 4, 7-Dichlororhodamine dyes
US5945526A (en) 1996-05-03 1999-08-31 Perkin-Elmer Corporation Energy transfer dyes with enhanced fluorescence
SE506700C2 (sv) 1996-05-31 1998-02-02 Mikael Kubista Sond och förfaranden för analys av nukleinsyra
US6008379A (en) 1997-10-01 1999-12-28 The Perkin-Elmer Corporation Aromatic-substituted xanthene dyes
ATE478090T1 (de) 1997-10-27 2010-09-15 Boston Probes Inc SICH AUF ßPNA MOLECULAR BEACONSß BEZIEHENDE VERFAHREN, TESTSÄTZE UND ZUSAMMENSETZUNGEN
US6485901B1 (en) 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
US5936087A (en) 1997-11-25 1999-08-10 The Perkin-Elmer Corporation Dibenzorhodamine dyes
US6140054A (en) 1998-09-30 2000-10-31 University Of Utah Research Foundation Multiplex genotyping using fluorescent hybridization probes
US6383752B1 (en) 1999-03-31 2002-05-07 Hybridon, Inc. Pseudo-cyclic oligonucleobases
US6140500A (en) 1999-09-03 2000-10-31 Pe Corporation Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use
US6528254B1 (en) 1999-10-29 2003-03-04 Stratagene Methods for detection of a target nucleic acid sequence
US6191278B1 (en) 1999-11-03 2001-02-20 Pe Corporation Water-soluble rhodamine dyes and conjugates thereof
US6596490B2 (en) 2000-07-14 2003-07-22 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
US6350580B1 (en) 2000-10-11 2002-02-26 Stratagene Methods for detection of a target nucleic acid using a probe comprising secondary structure
US6403341B1 (en) 2001-08-02 2002-06-11 Wayne M. Barnes Magnesium precipitate hot start method for PCR
AU2002334307A1 (en) 2001-09-04 2003-03-18 Exiqon A/S Novel lna compositions and uses thereof
US6593091B2 (en) 2001-09-24 2003-07-15 Beckman Coulter, Inc. Oligonucleotide probes for detecting nucleic acids through changes in flourescence resonance energy transfer
US20060078894A1 (en) 2004-10-12 2006-04-13 Winkler Matthew M Methods and compositions for analyzing nucleic acids
US7993831B2 (en) * 2007-09-14 2011-08-09 Asuragen, Inc. Methods of normalization in microRNA detection assays
WO2013063519A1 (en) * 2011-10-26 2013-05-02 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1370182A (zh) * 1999-04-02 2002-09-18 科里克萨有限公司 用于治疗和诊断肺癌的化合物和方法
CN1367829A (zh) * 1999-06-30 2002-09-04 科里克萨有限公司 用于肺癌治疗和诊断的组合物和方法
CN101284873A (zh) * 1999-06-30 2008-10-15 科里克萨有限公司 用于肺癌治疗和诊断的组合物和方法
CN101918594A (zh) * 2007-11-30 2010-12-15 俄亥俄州立大学研究基金会 肺癌中外周血中的微rna表达特征谱和靶向
CN102725632A (zh) * 2009-08-28 2012-10-10 奥斯瑞根公司 肺病的miRNA生物标志物
CN102858997A (zh) * 2009-11-02 2013-01-02 新加坡科技研究局 用于监测细胞状态和用于永生间充质干细胞的方法
WO2012107841A2 (en) * 2011-02-07 2012-08-16 Biomirna Holdings Ltd. Micro-rna biomarkers and methods of using same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOERI M等: "Role of micrornas in lung cancer: microrna signatures in cancer prognosis.", 《CANCER JOURNAL》 *
M.BOERI等: "MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer", 《PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES》 *
QIAN S等: "MicroRNA expression profile of bronchioaveolar stem cells from mouse lung", 《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114144836A (zh) * 2019-05-08 2022-03-04 丘比株式会社 信息提供装置和miRNA重要度表生成方法

Also Published As

Publication number Publication date
CA2935789A1 (en) 2015-07-09
JP2019122412A (ja) 2019-07-25
WO2015101653A1 (en) 2015-07-09
JP2017502699A (ja) 2017-01-26
IL246580A0 (en) 2016-08-31
JP6706208B2 (ja) 2020-06-03
ES2686631T3 (es) 2018-10-18
EP3090059B1 (en) 2018-06-06
US20210301350A1 (en) 2021-09-30
EP3090059A1 (en) 2016-11-09
US20150191794A1 (en) 2015-07-09
AU2014375224A1 (en) 2016-07-28
US20170204467A1 (en) 2017-07-20
BR112016015595A2 (pt) 2017-10-24
US20190119756A1 (en) 2019-04-25
IL246580B (en) 2020-11-30
EP3425066A1 (en) 2019-01-09

Similar Documents

Publication Publication Date Title
US20200370127A1 (en) Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers
CN103958695B (zh) 一种通过检测生物液体中miRNA来鉴定患早期肺癌的无症状高风险个体的方法
JP6720260B2 (ja) 癌を患うリスクのある被検体を診断するための方法およびキット
US20210301350A1 (en) Lung cancer determinations using mirna
US20200131586A1 (en) Methods and compositions for diagnosing or detecting lung cancers
WO2017223216A1 (en) Compositions and methods for diagnosing lung cancers using gene expression profiles
Gimondi et al. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation
EP2733220A1 (en) Novel miRNAs as diagnostic markers
CN103993093A (zh) 早期膀胱癌血清miRNAs特异表达谱及诊断模型
US20250137066A1 (en) Compostions and methods for diagnosing lung cancers using gene expression profiles
CN105518154A (zh) 脑癌检测
EP2657348A1 (en) Diagnostic miRNA profiles in multiple sclerosis
WO2014111561A1 (en) Serum mirna-142-3p as prognostic cancer marker
RU2779550C1 (ru) Способ для диагностирования рака яичников на основе набора генов длинных некодирующих РНК
CN112159847B (zh) 预测食管鳞状细胞癌淋巴结转移血清exosomal miRNAs的表达谱及诊断模型
US20220195522A1 (en) Mir-151a-3p as an universal endogenous control for exosome cargo normalization
Joung et al. 521 ASSOCIATION AND HAPLOTYPE ANALYSIS OF PROSTATE STEM CELL ANTIGEN WITH PROSTATE CANCER RISK
Kim et al. 522 EFEMP1 AS A NOVEL CANDIDATE DNA METHYLATION MARKER FOR PROSTATE CANCER: ARRAY-BASED DNA METHYLATION AND EXPRESSION PROFILING
Kim et al. 519 deregulation of Mir339 in Prostate CanCer and Metastases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20161123